SCHEMBL13784140

SCHEMBL13784140

CC(C)Cn1c(-c2ccc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc2)nc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.58
LMNA P02545 3/20 0.58
TSHR P16473 1/20 0.58
ALDH1A1 P00352 7/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KDM4E B2RXH2 7/20 0.54
HPGD P15428 4/20 0.54
PRKACA P17612 1/20 0.54
RPS6KB1 P23443 1/20 0.54
GSK3B P49841 1/20 0.54
ROCK1 Q13464 1/20 0.54
PDE6D O43924 1/20 0.52
ALDH2 P05091 1/20 0.52
ALDH3A1 P30838 1/20 0.52
TP53 P04637 2/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HTT P42858 2/20 0.49
NPC1 O15118 1/20 0.49
GLA P06280 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8228786 0.90 ALDH1A1 (0.67) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784137 0.85 KDM4E (0.68) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784132 0.83 KDM4E (0.66) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL31267426 0.82 KDM4E (0.72) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784139 0.81 TP53 (0.62) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22819342 0.80 KDM4E (0.73) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784141 0.80 KDM4E (0.64) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784142 0.78 KDM4E (0.50) HSD17B10LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL13784138 0.77 ALDH1A1 (0.65) HSD17B10LMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL31267379 0.77 ALDH1A1 (0.64) HSD17B10LMNAALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815412-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-08-26 US disclosed
US-8815412-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-08-26 US disclosed
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-23 US disclosed
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative H1-0, NQO2, GDI1 HSD17B10 3217/4885LMNA 2700/4885TSHR 3634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.